These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22748132)

  • 41. [First Argentine consensus guidelines for in vitro antimicrobial susceptibility testing of clinically relevant anaerobic bacteria in humans/ Anaerobic Subcommittee of the Asociación Argentina de Microbiología].
    Legaria MC; Bianchini HM; Castello L; Carloni G; Di Martino A; Fernández Canigia L; Litterio M; Rollet R; Rossetti A; Predari SC
    Rev Argent Microbiol; 2011; 43(1):51-66. PubMed ID: 21491069
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Review of immobilized antimicrobial agents and methods for testing.
    Green JB; Fulghum T; Nordhaus MA
    Biointerphases; 2011 Dec; 6(4):CL2-43. PubMed ID: 22239816
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Validity of nalidixic acid screening in fluoroquinolone-resistant typhoid salmonellae.
    Butt T; Khan MY; Ahmad RN; Salman M; Afzal RK
    J Coll Physicians Surg Pak; 2006 Jan; 16(1):31-4. PubMed ID: 16441985
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antimicrobial susceptibility of anaerobic bacteria in Auckland 1987-90.
    Henderson G; Garner J; Morris A
    N Z Med J; 1992 Jan; 105(926):11-2. PubMed ID: 1549266
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Institution-specific versus published in vitro antimicrobial susceptibility data in making formulary decisions.
    Franson TR; DaMert GJ; Sheth NK; Wisniewski T; Cooper JE; Johnson R; Babcock JB; Hoffmann RG; Malangoni MA
    Am J Hosp Pharm; 1987 Jan; 44(1):95-101. PubMed ID: 3826095
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Updating antimicrobial susceptibility testing: methods.
    Schofield CB
    Clin Lab Sci; 2012; 25(4):233-9. PubMed ID: 23330514
    [No Abstract]   [Full Text] [Related]  

  • 47. Halophiles and Their Biomolecules: Recent Advances and Future Applications in Biomedicine.
    Corral P; Amoozegar MA; Ventosa A
    Mar Drugs; 2019 Dec; 18(1):. PubMed ID: 31906001
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunogenic properties of the human gut-associated archaeon Methanomassiliicoccus luminyensis and its susceptibility to antimicrobial peptides.
    Bang C; Vierbuchen T; Gutsmann T; Heine H; Schmitz RA
    PLoS One; 2017; 12(10):e0185919. PubMed ID: 28982164
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methanogenic Archaea: Emerging Partners in the Field of Allergic Diseases.
    Sereme Y; Mezouar S; Grine G; Mege JL; Drancourt M; Corbeau P; Vitte J
    Clin Rev Allergy Immunol; 2019 Dec; 57(3):456-466. PubMed ID: 31522353
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Next-generation antimicrobial susceptibility testing.
    van Belkum A; Dunne WM
    J Clin Microbiol; 2013 Jul; 51(7):2018-24. PubMed ID: 23486706
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Archaea as emerging, fastidious members of the human microbiota.
    Drancourt M
    Clin Microbiol Infect; 2012 Sep; 18(9):823-4. PubMed ID: 22897826
    [No Abstract]   [Full Text] [Related]  

  • 52. New Antimicrobial Agents  …  but No Susceptibility Tests!
    Ambler JE; Krause KM; Steenbergen JN; Scangarella-Oman NE; Miller LA; Bhagwat SS; Serio AW; Chesnel L; Mahoney NM; Motyl MR; Critchley IA; Iaconis JP; Stone GG; Alder J; Xerri L; McCurdy SP; van Veenhuyzen DF; Grossman T; Echols RM; Williams G; Bradford PA
    Clin Infect Dis; 2016 Dec; 63(11):1530-1531. PubMed ID: 27581762
    [No Abstract]   [Full Text] [Related]  

  • 53. Halocins, natural antimicrobials of Archaea: Exotic or special or both?
    Kumar V; Singh B; van Belkum MJ; Diep DB; Chikindas ML; Ermakov AM; Tiwari SK
    Biotechnol Adv; 2021 Dec; 53():107834. PubMed ID: 34509601
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Archaea in and on the Human Body: Health Implications and Future Directions.
    Lurie-Weinberger MN; Gophna U
    PLoS Pathog; 2015 Jun; 11(6):e1004833. PubMed ID: 26066650
    [No Abstract]   [Full Text] [Related]  

  • 55. A reminder-peptidoglycan cell walls indeed occur in the archaeal domain, specifically in the members of Methanobacteria and Methanopyri classes.
    Mukhopadhyay B
    Front Microbiol; 2024; 15():1329047. PubMed ID: 38784805
    [No Abstract]   [Full Text] [Related]  

  • 56. The human archaeome in focus.
    Geesink P; Ettema TJG
    Nat Microbiol; 2022 Jan; 7(1):10-11. PubMed ID: 34969980
    [No Abstract]   [Full Text] [Related]  

  • 57. Archaea and their potential role in human disease.
    Eckburg PB; Lepp PW; Relman DA
    Infect Immun; 2003 Feb; 71(2):591-6. PubMed ID: 12540534
    [No Abstract]   [Full Text] [Related]  

  • 58. Archaea: Archaea shape up.
    van Ooij C
    Nat Rev Microbiol; 2011 May; 9(5):312. PubMed ID: 21494271
    [No Abstract]   [Full Text] [Related]  

  • 59. Osmoadaptation in archaea.
    Martin DD; Ciulla RA; Roberts MF
    Appl Environ Microbiol; 1999 May; 65(5):1815-25. PubMed ID: 10223964
    [No Abstract]   [Full Text] [Related]  

  • 60. The intestinal archaea Methanosphaera stadtmanae and Methanobrevibacter smithii activate human dendritic cells.
    Bang C; Weidenbach K; Gutsmann T; Heine H; Schmitz RA
    PLoS One; 2014; 9(6):e99411. PubMed ID: 24915454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.